ABCC6 p.Leu946Ile

[switch to full view]
Comments [show]
Publications
PMID: 12928920 [PubMed] Morcher M et al: "Heterozygous carriers of Pseudoxanthoma elasticum were not found among patients with cervical artery dissections."
No. Sentence Comment
45 However, the R1141X muTable ABCC6sequencevariationin12patientswithsCADand2patientswithPXE exon nucleotide Amino-acid Occurrence Occurrence position change among patients among controls 10 1233T¡C synonymous sCAD not tested 10 1245G¡A synonymous sCAD not tested 15 1890C¡G synonymous sCAD not tested 15 1896C¡A H623Q sCAD + 19 2490C¡T synonymous sCAD not tested 20 2631C¡A synonymous sCAD not tested 22 2835C¡T synonymous sCAD not tested 22 2836C¡A L946I PXE - 23 3190C¡T R1064W sCAD + 24 3389C¡T T1130M PXE - 27 3803G¡A R1268Q sCAD + tation is common in European patients, whereas a large deletion of exons 23-26 is repeatedly found in patients from the United States [22].
X
ABCC6 p.Leu946Ile 12928920:45:488
status: NEW
Login to comment

PMID: 15723264 [PubMed] Hendig D et al: "New ABCC6 gene mutations in German pseudoxanthoma elasticum patients."
No. Sentence Comment
94 Performing DHPLC and sequence analysis we also detected four different ABCC6 mutations (c.1995delG, p.R765Q, c.2787+1G>T, and p.L946I) which had already been categorized as PXE-causing mutations by other groups (Table 2) [9, 19, 20, 22].
X
ABCC6 p.Leu946Ile 15723264:94:128
status: NEW
Login to comment

97 Seven healthy control individuals were heterozygous for the missense mutation p.L946I, which was novel at the time of investigation.
X
ABCC6 p.Leu946Ile 15723264:97:80
status: NEW
Login to comment

131 Morcher et al. [22] considered the missense mutation p.L946I causative for a manifestation of PXE. This observation is not in accordance with the data that we obtained from a control cohort of 100 healthy Westphalian blood donors to investigate the role of p.L946I in PXE.
X
ABCC6 p.Leu946Ile 15723264:131:55
status: NEW
X
ABCC6 p.Leu946Ile 15723264:131:259
status: NEW
Login to comment

132 The appearance of p.L946I in the general population sheds doubt on the view that p.L946I is a disease-causing mutation but rather a polymorphism.
X
ABCC6 p.Leu946Ile 15723264:132:20
status: NEW
X
ABCC6 p.Leu946Ile 15723264:132:83
status: NEW
Login to comment

133 However, we cannot rule out the possibility that p.L946I has a phenotypic effect in a compound heterozygote with a severe mutation on the other allele.
X
ABCC6 p.Leu946Ile 15723264:133:51
status: NEW
Login to comment

PMID: 16086317 [PubMed] Miksch S et al: "Molecular genetics of pseudoxanthoma elasticum: type and frequency of mutations in ABCC6."
No. Sentence Comment
209 Type and Frequency of Polymorphisms in ABCC6 Identi'ed in170 Chromosomes of 81 PXE Familiesà Exon/ Intron Nucleotide substitution Amino acid change Location Frequency (] of families) Referencea E 03 c.232G4A p.A78T ABCC6-C2 81 This study, (C,H) IVS 03 c.345112T4C Intron duplication 81 This study IVS 03 c.345126C4T Intron 1 This study IVS 03 c.346À6G4A Intron 10 This study, (C) E 04 c.373G4A p.E125K ABCC6-C1 81 This study, (C) E 04 c.473C4T p.A158V ABCC6-C2 81 This study, (C) IVS 04 c.474113 G4A Intron duplication 2 This study IVS 04 c.474143C4T Intron duplication 80 This study, (C) IVS 04 c.475À76A4C Intron duplication 81 This study IVS 04 c.475À45C4T Intron 3 This study IVS 04 c.475À22T4C Intron duplication 80 This study, (C) E 05 c.549G4A L183L ABCC6 2 This study, (E) IVS 05 c.600123C4T Intron 1 This study E 06 c.645G4A T215T ABCC6 8 This study, (C) IVS 06 c.662112C4T Intron 1 This study, (C) E 07 c.793A4G R265G ABCC6-C1 81 This study, (C,H) IVS 07 c.794136A4C Intron duplication 81 This study, (C) E 08 c.841A4G K281E ABCC6-Cx 81 This study, (H) E 08 c.855C4T T285T ABCC6-C1 81 This study, (C) E 08 c.955A4G I319V ABCC6-Cx 81 This study, (H) E 09 c.1077A4G S359S ABCC6, ABCC6-C1 1 This study, (C,H) E 09 c.1132C4T Q378X ABCC6-C1 81 This study, (C,H) E 09 c.1141T4C L381L ABCC6, ABCC6-C1 81 This study, (C,H) IVS 09 c.117616C4T No SSM Intron 1 This study E 10 c.1233T4C N411N ABCC6 1 This study, (B,L) E 10 c.1245G4A V415V ABCC6 Frequent This study, (B,L) IVS 10 c.133817C4G Intron Frequent This study IVS 10 c.1338120C4G Intron Frequent This study IVS 10 c.1338162G4C Intron Frequent This study IVS 11 c.1432À41A4G Intron Frequent This study, (E) E 12 c.1540G4A V514I ABCC6 1 This study IVS 12 c.1635147C4T Intron Frequent This study E 14 c.1841T4C V614A ABCC6 Frequent This study, (B,E) IVS 14 c.1868À57G4A Intron 3 This study E 15 c.1890C4G T630T ABCC6 Frequent This study, (B,L) E 15 c.1896C4A H632Q ABCC6 Frequent This study, (C,G) E 17 c.2171G4A R724K ABCC6 2 This study E 17 c.2175A4T V725V ABCC6 2 This study E 17 c.2224A4G I742V ABCC6 2 This study E 19 c.2490C4T A830A ABCC6 Frequent This study, (E) E 22 c.2820T4G R940R ABCC6 1 This study E 22 c.2835C4T P945P ABCC6 8 This study, (J) E 22 c.2836C4A L946I ABCC6 3 This study E 22 c.2904G4A L968L ABCC6 1 This study, (J) E 23 c.3190C4T R1064W ABCC6 2 This study IVS 24 c.3507À16T4C No SSM Intron 4 This study IVS 24 c.3507À3C4T No SSM Intron 3 This study E 27 c.3803G4A R1268Q ABCC6 Frequent This study, (C,M) IVS 27 c.3883À24G4A Intron 1 This study IVS 28 c.4041149C4T Intron Frequent This study, (E) IVS 28 c.4042À30C4T Intron Frequent This study IVS 29 c.420819G4A Intron 2 This study E 30 c.4305C4T G1435G ABCC6 1 This study IVS 30 c.4405À31G4A Intron Frequent This study 30 UTR c.4512117G4A UTR 5 This study, (E) 30 UTR c.4512138G4A UTR 1 This study ÃDNA mutation numbering is based on the ABCC6 cDNA sequence (GenBank accession no. AF076622.1) and 11 corresponds to the A of the ATG translation initiation codon of the reference sequence.
X
ABCC6 p.Leu946Ile 16086317:209:2260
status: NEW
Login to comment

199 Coding sequence SNPs were considered as neutral (non-disease-causing) when they resulted in a synonymous amino acid substitution or a nonsynonymous substitution that did not cosegregate with the disease haplotype and phenotype (p.V614A, p.R724K, p.I742V, p.L946I, p.R1064W, and p.R1268Q) or did cosegregate with other PXE mutations in linkage disequilibrium in individual families (p.V514I, p.H632Q, and p.R1268Q).
X
ABCC6 p.Leu946Ile 16086317:199:257
status: NEW
Login to comment

PMID: 19339160 [PubMed] Ramsay M et al: "Spectrum of genetic variation at the ABCC6 locus in South Africans: Pseudoxanthoma elasticum patients and healthy individuals."
No. Sentence Comment
100 Three rare missense variants, A78T, L726P and L946I, were each identified once and were characterised.
X
ABCC6 p.Leu946Ile 19339160:100:46
status: NEW
Login to comment

105 Two of these, L726P and L946I, were present in a single white bilingual South African patient (PXE2), the father was a carrier of L726P and the mother of L946I, confirming that they were inherited as independent alleles.
X
ABCC6 p.Leu946Ile 19339160:105:24
status: NEW
X
ABCC6 p.Leu946Ile 19339160:105:154
status: NEW
Login to comment

111 L946I is a conservative amino acid change from leucine (L) to isoleucine (I) (both amino acids are non-polar, neutral and hydrophobic) in the transmembrane domain (TMD) of ABCC6.
X
ABCC6 p.Leu946Ile 19339160:111:0
status: NEW
Login to comment

149 998+13C>T - Intron - 1 - This study E 10 c.1233T>C N411N CL3 1 2 1 [32,35] rs9930886 E 10 c.1245G>A V415V CL4 - 2 - [32,35] rs9940825 E 10 c.1249G>A V417M CL4 5 - - This study IVS 10 c.1338+7C>G - Intron - 5 - [32] rs9940089 E 11 c.1344G>A L448L EL5 - 2 - This study IVS 11 c.1432-41A>C - Intron 3 1 2 [7,32] rs2239322 IVS 11 c.1432-45C>T - Intron - - 2 [11] No rs number IVS 11 c.1432-48G>A - Intron 7 - 8 dbSNP rs7193932 E 12 c.1494G>A K499K CL4 - - 1 This study IVS 12 c.1635+48C>T** - Intron 7 - - [32] ENSSNP11084760 E 14 c.1841T>C V614A CL5 15 2 3 [7,32,35] rs12931472 E 15 c.1890C>G T630T CL5 6 3 1 [32,35] rs8058696 E 16 c.1896C>A H632Q CL5 - 3 1 [31,32,36] rs8058694 E 17 c.2171G>A*** R724L NBF1 - 1 - [32] No rs number E 17 c.2175A>T V725V NBF1 - 2 - [32] No rs number E 17 c.2224A>G I742V NBF1 - 1 - [32] No rs number E 18 c.2400A>G G800G NBF1 1 2 - dbSNP rs7500834 E 19 c.2490C>T A830A CL6 3 - - [7,32] rs9924755 E 19 c.2542A>G M848V CL6 1 3 - dbSNP rs6416668 E 22 c.2835C>T P945P TS12 1 2 1 [32,37] rs2856585 E 22 c.2836C>A L946I TS12 1 - - This studya IVS 24 c.3507-16T>C - Intron 3 2 - [11,32] rs3213471 a L946I was previously identified as a pathogenic mutation by Morcher et al. [38], in this study bioinformatic analysis of the variant did not support a functional effect of the variant on the protein.
X
ABCC6 p.Leu946Ile 19339160:149:1037
status: NEW
X
ABCC6 p.Leu946Ile 19339160:149:1121
status: NEW
Login to comment

PMID: 17251343 [PubMed] Shi Y et al: "Development of a rapid, reliable genetic test for pseudoxanthoma elasticum."
No. Sentence Comment
105 The one patient DNA, patient 10, that lacked mutations in the regions tested was found to have the mutation c.2836CϾA (p.L946I) in exon 22 by denaturing high-performance liquid chromatography and DNA sequencing (data not shown).
X
ABCC6 p.Leu946Ile 17251343:105:127
status: NEW
Login to comment

PMID: 19726431 [PubMed] De Zaeytijd J et al: "Added value of infrared, red-free and autofluorescence fundus imaging in pseudoxanthoma elasticum."
No. Sentence Comment
78 In 55% of fundi (24/44), the Table 1 Ophthalmological characteristics of patients Case Age, sex Eye BCVA AS Pd`O C(T) ODD NV PDT Anti-VEGF ABCC6 mutations 1 61, F OD 2/10 + + + À + + À p.R1459C/e OS 9/10 + + + À + + À 2 43, F OD 12/10 + + + À À À À p.R1141X/p.R1141X OS 12/10 + + + À À À À 3 35, M OD 11/10 + + + À À À À p.E125K/p.L1025P OS 1/300 + + + À + + + 4 21, M OD 10/10 + + + À À À À p.R1141X/p.R1141X OS 10/10 + + + + À À À 5 11, M OD 10/10 À + + À À À À c.3506+2T/C/e 3506+2T/COS 10/10 À + + À À À À 6 55, F OD 1/20 + + + À + À À p.R1141X/p.R1141X OS 1.5/10 + + + À + À À 7 40, M OD 4/10 + + + À + + À p.R265G/p.R1141X OS 1/10 + + + À + + À 8 22, F OD 10/10 + + + À À À À p.R1141X/p.R1141X OS 10/10 + + + À À À À 9 29, F OD 10/10 + + + À À À À p.G1263R/c.4182delGG OS 10/10 + + + À À À À 10 20, M OD 10/10 + + + + À À À c.3507-3C/A/p.T944I OS 10/10 + + + + À À À 11 37, F OD 10/10 + + + + À À À p.Q154R/e OS 9/10 + + + + À À À 12 66, F OD 1/20 + À À À + À À p.R1141X/p.R1141X OS 1/10 + À À À + À À 13 68, F OD 10/10 + À À À À À À p.R760Q/p.R1141X OS 10/10 + À À À À À À 14 68, M OD 2/10 + À + À + À À p.A1303P/p.L946I OS CF + À + À + À À 15 58, F OD 7/10 + + + À + À + p.R1141X/c.4103delC OS CF + + + À + + À 16 62,M OD 1/20 + + + À + À + p.R1141X/p.Q1237X OS CF + + + À + À À 17 47, F OD 10/10 + À À À À À À c.3506+2T/C/e OS 10/10 + À À À À À À 18 54, F OD 10/10 + + + À + À + p.R1141X/p.A1303P OS 10/10 + + + À À À À 19 30, F OD 10/10 + + + À À À À p.S398R/c.3364delT OS 10/10 + + + À À À À 20 39, F OD 12/10 + + + À À À À p.R1141X/e OS 10/10 + + + À À À À 21 30, F OD 10/10 + + + À À À À p.G666R/c.1868-5T/G OS 10/10 + + + + À À À 22 34, M OD 12/10 + + + À À À À c.3364delT/p.R518X OS 12/10 + + + À À À À anti-VEGF, anti-vascular endothelial growth factor antibodies; AS, angioid streaks; BCVA, best-corrected visual acuity (Snellen); CF, counting fingers; C(T), Comet (tails); F, female; M, male; MD, macular degeneration; NV, neovascularisation; ODD, optic disc drusen; Pd`O, Peau d`Orange; PDT, photodynamic therapy.
X
ABCC6 p.Leu946Ile 19726431:78:1612
status: NEW
Login to comment

PMID: 25062064 [PubMed] Hosen MJ et al: "Molecular docking simulations provide insights in the substrate binding sites and possible substrates of the ABCC6 transporter."
No. Sentence Comment
226 (Phe568Ser) L946 2836C.A L946I Missense 22 p.
X
ABCC6 p.Leu946Ile 25062064:226:25
status: NEW
Login to comment

227 (Leu946Ile) L953 2868T.A L953H Missense 22 p.
X
ABCC6 p.Leu946Ile 25062064:227:1
status: NEW
Login to comment